September 2026
The global prostate cancer diagnostics market size is expected to hit around USD 18 billion by 2035 from USD 10.34 billion in 2026 , with a CAGR of 6.36%.
September 2026
The global non-invasive cancer diagnostics market size is projected to hit around USD 350.78 billion by 2035 from USD 185.94 billion in 2026, with a CAGR of 7.32%.
September 2026
The breast cancer diagnostics market size is valued at USD 21.78 billion in 2026 and is projected to hit around USD 43.62 billion by 2035 with a CAGR of 8.03%.
September 2026
The global blood cancer diagnostics market size is estimated to hit around USD 22.55 billion by 2035 increasing from USD 12.46 billion in 2026, with a CAGR of 6.83%.
September 2026
The global cancer diagnostics market size was exhibited at USD 184.96 billion in 2026 and is predicted to surpass around USD 378.44 billion by 2035 with a CAGR of 8.33%.
June 2026
The global bladder cancer therapeutics diagnostics market size was valued at USD 5.68 billion in 2025 and is expected to hit around USD 10.04 billion by 2035, growing at a CAGR of 5.86%.
June 2026
The colorectal cancer diagnostics market size reached USD 16.9 billion in 2025 and is estimated to hit around USD 38.66 billion by 2035 with a CAGR of 8.63%.
May 2026
The global next-generation cancer diagnostics market size is projected to hit around USD 46.43 billion by 2035 from USD 19.16 billion in 2025, with a CAGR of 9.25%.
December 2025
The global prostate cancer market size is calculated at USD 12.88 billion in 2025 and is projected to hit around USD 28.83 billion by 2035 with a CAGR of 8.41%.
December 2025
The global gastric cancer diagnostics market size is evaluated at USD 1.32 billion in 2025 and is predicted to hit around USD 2.72 billion by 2035, growing at a CAGR of 7.51%.
November 2025
The global lung cancer diagnostics market size is estimated at USD 5.35 billion in 2025 and is predicted to hit around USD 9.45 billion by 2034 with a CAGR of 6.53%.
July 2026
The U.S. oncology molecular diagnostics market size is projected to surge USD 2,740 million by 2035 from USD 880 million in 2025 with a notable CAGR of 12.03%.
July 2025
The global biopsy needle market size is expected to attain around USD 2.82 billion by 2034 from USD 1.39 billion in 2024 with a CAGR of 7.33%.
September 2026
The cancer immunotherapy market size is calculated at USD 151.26 billion in 2026 and is projected to hit around USD 367.63 billion by 2035, at a CAGR of 10.42%.
September 2026
The oncology/cancer drugs market size is calculated at USD 214.70 billion in 2026 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
September 2026
The global home diagnostics market size accounted for USD 7.28 billion in 2026 and is expected to reach USD 11.54 billion by 2035, growing at a CAGR of 5.26%.
September 2026
The infectious respiratory disease diagnostics market size was USD 60.62 billion in 2026, with leading infectious respiratory disease diagnostics market players including F. Hoffmann - La Roche, Thermo Fisher Scientific, Danaher (Cepheid), Abbott LaboratoriesÂ
September 2026
The molecular diagnostics market size is calculated at USD 46.61 billion in 2026 and is expected to hit around USD 66.34 billion by 2035 with a CAGR of 3.93%.
September 2026
The global tuberculosis diagnostics market size is calculated at USD 2.70 billion in 2026 and is projected to hit around USD 4.08 billion by 2034 with a CAGR of 5.30%.
September 2026
The epigenetics diagnostics market size was evaluated at USD 22.40 billion in 2026 and is predicted to worth around USD 67.26 billion by 2034, with a CAGR of 14.81%.
September 2026
The global in vitro diagnostics quality controls market size is estimated to hit around USD 2,713.92 million by 2035, increasing from USD 1,736.17 million in 2026, with a CAGR of 5.09%.
September 2026
The global HIV diagnostics market size was evaluated at USD 1.41 billion in 2026 and is predicted to hit around USD 2.24 billion by 2035, growing at a CAGR of 5.26%.
September 2026
The global transplant diagnostics market size is expected to increase from USD 5.22 billion in 2026 to hit around USD 9.24 billion by 2035, growing at a CAGR of 6.55%.
September 2026
The global point-of-care diagnostics market size is exhibited at USD 65.94 billion in 2026 and is predicted to be worth around USD 85.03 billion by 2035 with a CAGR of 2.87%.
September 2026
The global fallopian tube cancer therapeutics market size is expected to increase from USD 2.14 billion in 2026 to hit around USD 5.41 billion by 2035, growing at a CAGR of 10.86%.
September 2026
The global colorectal cancer therapeutics market size is expected to hit around USD 19.95 billion by 2034 from USD 12.79 billion in 2024 with a CAGR of 4.55%.
September 2026
The global infectious disease molecular diagnostics market size is estimated to hit around USD 63.37 billion by 2034 with a CAGR of 3.25% from 2026 to 2034.
September 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.83 billion in 2026, with a CAGR of 9.70%.
September 2026
The global sexually transmitted diseases diagnostics market size is estimated to hit around USD 21.44 billion by 2034 from USD 12.26 billion in 2026, with a CAGR of 7.24%.
September 2026
The global cardiac AI monitoring and diagnostics market size was evaluated at USD 5.17 billion in 2026 and is predicted to hit around USD 18.89 billion by 2035, growing at a CAGR of 15.48%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com